Osaic Holdings’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
Other funds holding PTCT
RI
JT
Osaic Holdings's PTCT Position: Q2 2026 in Review
Osaic Holdings reduced its PTC Therapeutics (PTCT) stake by 3.6% in Q2 2026, selling an estimated $1.3K and leaving 484 shares worth $39.5K. The position accounts for ﹤0.01% of the portfolio, ranked #5647.
Osaic Holdings first reported a position in PTCT in Q1 2020 and has held it in 26 quarters since. The position peaked at $62K in Q2 2020. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.
- Osaic Holdings held 484 shares of PTC Therapeutics worth $39.5K as of Q2 2026.
- Osaic Holdings sold 18 PTC Therapeutics shares in Q2 2026, an estimated $1.3K.
- PTC Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #5647 holding.
- Osaic Holdings first reported a position in PTC Therapeutics in Q1 2020 and has held it in 26 quarters since.
- Osaic Holdings's PTC Therapeutics position peaked at $62K in Q2 2020.
- 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.
Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.